{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:10:31Z","timestamp":1788120631504,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":669,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/jto.0000000000000062","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T04:34:05Z","timestamp":1389674045000},"page":"222-230","source":"Crossref","is-referenced-by-count":16,"title":["Phase II Study of Perioperative Chemotherapy with Cisplatin and Pemetrexed in Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"9","author":[{"given":"Grace K.","family":"Dy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd L.","family":"Demmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikrishna S.","family":"Yendamuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwumere E.","family":"Nwogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Bushunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araba A.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex A.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0000000000000062_bib1","first-page":"11","article-title":"Cancer statistics, 2013","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/JTO.0000000000000062_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.20.1.247","article-title":"Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer","volume":"20","author":"Depierre","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0169-5002(99)00045-8","article-title":"Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial","volume":"26","author":"Rosell","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0000000000000062_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jnci\/86.9.673","article-title":"A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer","volume":"86","author":"Roth","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0000000000000062_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(55)92787-2","article-title":"Combined radiotherapy and resection for carcinoma of the bronchus; experiences with 66 patients","volume":"269","author":"Bromley","year":"1955","journal-title":"Lancet"},{"key":"10.1097\/JTO.0000000000000062_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5223(19)42513-0","article-title":"Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma","volume":"59","author":"Shields","year":"1970","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0000000000000062_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-5002(97)00658-2","article-title":"Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)","volume":"17","author":"Elias","year":"1997","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0000000000000062_bib8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0003-4975(93)91072-U","article-title":"Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients","volume":"55","author":"Martini","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0000000000000062_bib9","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1200\/JCO.1993.11.9.1757","article-title":"Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials","volume":"11","author":"Pisters","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib10","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib11","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0000000000000062_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"International Adjuvant Lung Cancer Trial Collaborative Group. . Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0000000000000062_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib14","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/JCO.2009.25.5109","article-title":"Adjuvant chemotherapy for non-small-cell lung cancer: it does not always fade with time","volume":"28","author":"Douillard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib16","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3892\/etm.2012.730","article-title":"Correlation between thymidylate synthase gene polymorphisms and efficacy of pemetrexed in advanced non-small cell lung cancer","volume":"4","author":"Hu","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1097\/JTO.0000000000000062_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.lungcan.2012.07.009","article-title":"Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin","volume":"78","author":"Tiseo","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0000000000000062_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2008.19.1650","article-title":"Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer","volume":"27","author":"Smit","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/JTO.0b013e3181ec18c4","article-title":"Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study","volume":"5","author":"Adjei","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1200\/JCO.2009.23.6406","article-title":"Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426","volume":"28","author":"Adjei","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib21","first-page":"4455","article-title":"Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer","volume":"25","author":"Takehara","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1097\/JTO.0000000000000062_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0000000000000062_bib23","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib24","first-page":"189","article-title":"Mediastinal lymph node dissection for lung cancer. The Memorial experience","volume":"5","author":"Martini","year":"1995","journal-title":"Chest Surg Clin N Am"},{"key":"10.1097\/JTO.0000000000000062_bib25","unstructured":"http:\/\/clinicaltrials.gov. Accessed December 11, 2013."},{"key":"10.1097\/JTO.0000000000000062_bib26","unstructured":"http:\/\/clinicaltrials.gov\/show\/NCT00389688. Accessed December 11, 2013."},{"key":"10.1097\/JTO.0000000000000062_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1200\/JCO.2010.33.7089","article-title":"Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer","volume":"30","author":"Scagliotti","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib28","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1200\/JCO.2009.27.6204","article-title":"Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer","volume":"28","author":"Felip","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib29","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(07)60714-4","article-title":"Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22\/NVALT 2\/EORTC 08012 multicentre randomised trial and update of systematic review","volume":"369","author":"Gilligan","year":"2007","journal-title":"Lancet"},{"key":"10.1097\/JTO.0000000000000062_bib30","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1200\/JCO.2009.26.1685","article-title":"Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial","volume":"28","author":"Pisters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib31","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1200\/JCO.2002.08.092","article-title":"Long-term results of combined-modality therapy in resectable non-small-cell lung cancer","volume":"20","author":"Martin","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib32","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/JTO.0b013e3182209043","article-title":"Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: a Brown University oncology group phase II study","volume":"6","author":"Ahmed","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib33","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","article-title":"Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial","volume":"21","author":"Betticher","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib34","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1378\/chest.128.5.3467","article-title":"Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer","volume":"128","author":"Ramnath","year":"2005","journal-title":"Chest"},{"key":"10.1097\/JTO.0000000000000062_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/JTO.0b013e3182352a45","article-title":"Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy","volume":"7","author":"Hou","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib36","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0003-4975(00)01585-X","article-title":"Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival","volume":"70","author":"Bueno","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0000000000000062_bib37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jtcvs.2011.07.059","article-title":"Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer","volume":"142","author":"Higgins","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0000000000000062_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jtcvs.2010.02.018","article-title":"Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients","volume":"140","author":"Stefani","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0000000000000062_bib39","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/annonc\/mdr563","article-title":"Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer","volume":"23","author":"Smit","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0000000000000062_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/FPC.0b013e328329fdec","article-title":"Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity","volume":"19","author":"Peters","year":"2009","journal-title":"Pharmacogenet Genomics"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415301933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415301933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:09:44Z","timestamp":1597378184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415301933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1556086415301933"],"URL":"https:\/\/doi.org\/10.1097\/jto.0000000000000062","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}